GRAL Competitors & Alternatives
Compare GRAIL, LLC with similar stocks in the same industry
Diagnostics & Research
GRAL
Main Stock$59.65
Tradestie Score
59
Market Cap
$2.24B
Revenue Growth
0.3%
Analyst Upside
+12.1%
Top Competitors
34 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BLLN
BLLN
|
$82.63
|
$4.04B | 159.9 | 54 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$40.75
|
$3.26B | - | 54 | Compare |
|
VCYT
Veracyte, Inc.
|
$38.48
|
$2.85B | 36.0 | 56 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$12.83
|
$2.22B | - | 55 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$49.17
|
$1.77B | - | 57 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$38.69
|
$1.50B | - | 56 | Compare |
|
NEOG
Neogen Corp
|
$8.19
|
$1.26B | - | 50 | Compare |
|
OPK
Opko Health Inc.
|
$1.10
|
$1.23B | - | 56 | Compare |
|
NEO
NeoGenomics, Inc.
|
$8.24
|
$1.13B | - | 54 | Compare |
|
CDNA
CareDx, Inc.
|
$19.97
|
$798.40M | - | 49 | Compare |
More GRAL Analysis
Data updated: May 18, 2026 | Industry: Diagnostics & Research (SIC 8071)
34 stocks in this industry